Eigen Therapeutics is focused on tackling tumor heterogeneity by designing combination therapies that improve the efficacy of targeted cancer treatments
Eigen Therapeutics is focused on tackling tumor heterogeneity by designing combination therapies that improve the efficacy of targeted cancer treatments. Their platform utilizes machine learning and automation to develop co-therapies that enhance treatment outcomes while reducing side effects.